With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|The Impact of Hypoxia on Epigenetic Changes in Neuroblastoma||University of Chicago / Sakshi Uppal, PhD||Young Investigator Grants||2017||Illinois|
|PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia||Massachusetts General Hospital / Jessica Blackburn, PhD||Young Investigator Grants||2013||Massachusetts|
|Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma||Boston Children's Hospital / Shuibin Lin, PhD||Young Investigator Grants||2017||Massachusetts|
|Optimizing Engager T-cells for CD19+ Malignancies||Baylor College of Medicine / Mireya Paulina Velasquez, MD||Young Investigator Grants||2014||Texas|
|Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells||Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD||Young Investigator Grants||2014||Washington|
|The Role of Inhibition of Apoptosis by C/EBPalpha and C/EBPalpha oncoproteins in AML.||The Johns Hopkins University School of Medicine / Ido Paz-Priel, MD||Young Investigator Grants||2007||Maryland|
|Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD||Young Investigator Grants||2012||Washington|
|Integration of Targeted New Agents with Chemotherapy||Children's Hospital of Philadelphia / Robin Norris, MD||Young Investigator Grants||2008||Pennsylvania|
|TLE1 Tumor Suppressor as a Key Regulator of myc Induced Leukemia||Massachusetts General Hospital / Selvi Ramasamy||Young Investigator Grants||2010||Massachusetts|
|Exploring a novel immunotherapy: cooperation of endogenous CD8+ t-cells and exogenous, allogeneic CD4+ t-cells.||The Johns Hopkins University School of Medicine / Heather Symons||Young Investigator Grants||2009||Maryland|